Showing results (2071-2080 of 5,146) with videos related to
Sort By:
Pageof 515
Multiple Sclerosis and Related Disorders|May 15, 2020
Cognitive reserve is a determinant of social and occupational attainment in patients with pediatric and adult onset multiple sclerosisPortaccio E, Simone M, Prestipino E, et al.Multiple Sclerosis and Related Disorders|May 15, 2020
Safety and feasibility of various fasting-mimicking diets among people with multiple sclerosisS N Roman, K C Fitzgerald, M Beier, et al.Multiple Sclerosis and Related Disorders|February 15, 2023
Comparative efficacy and safety of ozanimod and ponesimod for relapsing multiple sclerosis: A matching-adjusted indirect comparisonElyse Swallow, Timothy Pham, Oscar Patterson-Lomba, et al.Multiple Sclerosis and Related Disorders|January 30, 2023
Electronic health record data for assessing risk of hospitalization for COVID-19: Methodological considerations applied to multiple sclerosisPaul Dillon, Athanasios Siadimas, Spyros Roumpanis, et al.Multiple Sclerosis and Related Disorders|February 11, 2023
Effectiveness of ocrelizumab on clinical and MRI outcome measures in multiple sclerosis across black and white cohorts: A single-center retrospective studyAmanda Frisosky Abuaf, Adil Javed, Samuel R Bunting, et al.Multiple Sclerosis and Related Disorders|February 22, 2023
Vascular function and cognition in persons with multiple sclerosis: Preliminary examinationPeixuan Zheng, Lara A Pilutti, Noah G DuBose, et al.Multiple Sclerosis and Related Disorders|February 22, 2023
Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohortLodewijk R J de Ruiter, Floor C Loonstra, Julia R Jelgerhuis, et al.Multiple Sclerosis and Related Disorders|January 29, 2023
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosisAntonio Bruno, Ettore Dolcetti, Federica Azzolini, et al.Multiple Sclerosis and Related Disorders|March 1, 2023
Impact of COVID-19 on prescribing patterns and treatment selection of disease modifying therapies in multiple sclerosisReemal Zaheer, Roma Amin, LaTasha Riddick, et al.Multiple Sclerosis and Related Disorders|March 4, 2023
Neuropathologically informed imaging of cortical grey matter lesions in MS - A pilot studyS Quigley, M C Yiannakas, P Bede, et al.Pageof 515